SPOTLIGHT: FDA gives nod to Ranbaxy's generic Diovan


India's Ranbaxy Laboratories got a tentative FDA OK for a generic version of the Novartis drug Diovan, used to treat high blood pressure and heart failure. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.